Telesis Bio, Inc. (TBIO)
OTCMKTS
· Delayed Price · Currency is USD
0.443
+0.063 (16.58%)
Dec 26, 2024, 4:00 PM EST
Telesis Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -45.55 | -47.72 | -48.47 | -38.96 | -18.01 | -9.96 |
| Depreciation & Amortization | 4.4 | 4.1 | 2.88 | 1.57 | 1.46 | 1.03 |
| Other Amortization | 0.22 | 0.77 | 0.48 | 0.48 | 0.21 | 0.06 |
| Loss (Gain) From Sale of Assets | 0.33 | 0.14 | 0 | 0.03 | - | 0.23 |
| Asset Writedown & Restructuring Costs | 12.74 | 11.63 | - | - | 0.07 | - |
| Loss (Gain) From Sale of Investments | -0.5 | -0.64 | -0.18 | - | - | - |
| Stock-Based Compensation | 2.82 | 3.96 | 3.73 | 1.09 | 0.04 | 0.01 |
| Provision & Write-off of Bad Debts | 0.83 | 1.2 | 0.34 | - | - | - |
| Other Operating Activities | 1.57 | -0.33 | 0.72 | 2.13 | 0.86 | 0.69 |
| Change in Accounts Receivable | 2.55 | -1.33 | -2.53 | -0.74 | -0.77 | -1.03 |
| Change in Inventory | 1.96 | -1.83 | 0.17 | -1.46 | 0.11 | 0.87 |
| Change in Accounts Payable | -2.13 | -3.29 | 1.16 | 4.39 | 1.4 | 0.28 |
| Change in Unearned Revenue | -0.89 | -3.67 | 3.74 | -0.54 | 0.5 | -0.02 |
| Change in Other Net Operating Assets | -0.65 | 2.34 | -0.76 | -4.69 | -1.26 | 0.17 |
| Operating Cash Flow | -22.87 | -34.67 | -38.72 | -36.7 | -15.38 | -7.67 |
| Capital Expenditures | -0.99 | -1.98 | -4.47 | -1.85 | -0.2 | -0.09 |
| Sale of Property, Plant & Equipment | 0.02 | 0.02 | - | - | - | - |
| Cash Acquisitions | - | - | -0.56 | -13.19 | - | - |
| Investment in Securities | 23.77 | -3.78 | -12.98 | - | - | - |
| Investing Cash Flow | 24.33 | -5.74 | -18.01 | -15.04 | -0.2 | -0.09 |
| Long-Term Debt Issued | - | - | 19.76 | 14.87 | - | - |
| Total Debt Issued | 5.67 | - | 19.76 | 14.87 | - | 14.1 |
| Long-Term Debt Repaid | - | -15.09 | -15.08 | -5.08 | -0.11 | - |
| Total Debt Repaid | -20.11 | -15.09 | -15.08 | -5.08 | -0.11 | -10.83 |
| Net Debt Issued (Repaid) | -14.44 | -15.09 | 4.68 | 9.79 | -0.11 | 3.27 |
| Issuance of Common Stock | 0.05 | 0.24 | 0.58 | 121.24 | 0.01 | - |
| Other Financing Activities | -1.82 | 7.01 | -0.75 | -9.95 | - | -0.68 |
| Financing Cash Flow | -15.22 | 11.57 | 4.51 | 121.08 | -0.1 | 42.13 |
| Foreign Exchange Rate Adjustments | 0.01 | -0 | - | - | - | - |
| Net Cash Flow | -13.75 | -28.85 | -52.21 | 69.34 | -15.68 | 34.36 |
| Free Cash Flow | -23.86 | -36.65 | -43.18 | -38.55 | -15.59 | -7.76 |
| Free Cash Flow Margin | -140.08% | -133.22% | -157.40% | -349.11% | -237.00% | -134.63% |
| Free Cash Flow Per Share | -13.95 | -22.10 | -26.38 | -38.08 | -56.09 | -27.95 |
| Cash Interest Paid | 0.89 | 2.23 | 1.38 | 0.83 | 0.46 | 1.59 |
| Cash Income Tax Paid | 0.01 | 0.02 | - | - | - | - |
| Levered Free Cash Flow | -10.21 | -23.24 | -23.83 | -23.77 | -8.68 | - |
| Unlevered Free Cash Flow | -9.7 | -22.06 | -23.09 | -23.39 | -8.46 | - |
| Change in Net Working Capital | -3.61 | 6.18 | -3.83 | 2.28 | -0.47 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.